Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Daniotti

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Lancet (London, England)|November 17, 1984
Seasonal prophylactic treatment with pirenzepine to prevent duodenal ulcer recurrenceA Morelli, F Narducci, M A Pelli, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Long-term treatment of duodenal ulcer with pirenzepine. A double-blind, placebo-controlled trialP R Dal Monte, G Bianchi Porro, M Petrillo, et al.
Digestion|January 1, 1982
Pirenzepine versus cimetidine in duodenal ulcer. A double-blind, placebo-controlled, short-term clinical trialG Bianchi Porro, P R Dal Monte, M Petrillo, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjectsB P Imbimbo, M Seiberling, U Peuckert, et al.
Scandinavian Journal of Gastroenterology|November 1, 1988
Manometric evaluation of cimetropium bromide activity in patients with the nutcracker oesophagusG Bassotti, M Gaburri, B P Imbimbo, et al.
Recenti Progressi in Medicina|April 1, 1983
[Management of hyperlipoproteinemias]A Battocchia, S Girotto, P Residori, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trialM Giorgi-Conciato, S Daniotti, P A Ferrari, et al.
British Journal of Clinical Pharmacology|October 1, 1988
Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteersB P Imbimbo, R Urso, G Thieme, et al.
Journal of Clinical Pharmacology|August 1, 1982
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjectsT Meloni, G Forteleoni, M Serra, et al.
Minerva Dietologica E Gastroenterologica|October 1, 1989
[Preventive role of pirenzepine in gastric damage during cytostatic therapy. A controlled randomized double-blind study with placebo]A Contu, G Marenco, P Pani, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Lancet (London, England)|November 17, 1984
Seasonal prophylactic treatment with pirenzepine to prevent duodenal ulcer recurrenceA Morelli, F Narducci, M A Pelli, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Long-term treatment of duodenal ulcer with pirenzepine. A double-blind, placebo-controlled trialP R Dal Monte, G Bianchi Porro, M Petrillo, et al.
Digestion|January 1, 1982
Pirenzepine versus cimetidine in duodenal ulcer. A double-blind, placebo-controlled, short-term clinical trialG Bianchi Porro, P R Dal Monte, M Petrillo, et al.
European Journal of Clinical Pharmacology|January 1, 1988
Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjectsB P Imbimbo, M Seiberling, U Peuckert, et al.
Scandinavian Journal of Gastroenterology|November 1, 1988
Manometric evaluation of cimetropium bromide activity in patients with the nutcracker oesophagusG Bassotti, M Gaburri, B P Imbimbo, et al.
Recenti Progressi in Medicina|April 1, 1983
[Management of hyperlipoproteinemias]A Battocchia, S Girotto, P Residori, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1982
Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trialM Giorgi-Conciato, S Daniotti, P A Ferrari, et al.
British Journal of Clinical Pharmacology|October 1, 1988
Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteersB P Imbimbo, R Urso, G Thieme, et al.
Journal of Clinical Pharmacology|August 1, 1982
Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjectsT Meloni, G Forteleoni, M Serra, et al.
Minerva Dietologica E Gastroenterologica|October 1, 1989
[Preventive role of pirenzepine in gastric damage during cytostatic therapy. A controlled randomized double-blind study with placebo]A Contu, G Marenco, P Pani, et al.
Pageof 4